Type 2 diabetes trials in Kazakhstan

In Kazakhstan 7 Also abroad 1200

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Aktobe, Almaty
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
No phaseTaking people
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Where
Almaty
Age
21 years to 65 years
People
120
Run by
Kazakh Academy of Nutrition
See details and how to joinNCT07728669
No phaseTaking people
The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
Where
Astana
Age
18 years to 65 years
People
90
Run by
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
See details and how to joinNCT07495020
No phaseTaking people
Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
Where
Aktobe
Age
18 years to 74 years
People
310
Run by
West Kazakhstan Marat Ospanov Medical University
See details and how to joinNCT07512934
Phase 4Taking people
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Where
Astana
Age
35 years to 65 years
People
220
Run by
University Medical Center, Kazakhstan
See details and how to joinNCT06410352
No phaseTaking people
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Where
Almaty
Age
18 years to 69 years
People
6,720
Run by
Asfendiyarov Kazakh National Medical University
See details and how to joinNCT06953180
No phaseEnrolling by invitation
Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population
Where
Astana
Age
18 years to 65 years
People
100
Run by
Astana Medical University
See details and how to joinNCT07038213